Female Androgenetic Alopecia Clinical Trial
Official title:
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
The investigators propose to conduct a head-to-head, randomized clinical trial to compare the effectiveness of Minoxidil with Spironolactone and Finasteride in treating postmenopausal females with Androgenetic Alopecia (AGA).
Participants diagnosed with AGA will be randomized into one of the two treatment arms
outlined below, and will take the assigned treatment for a total duration of 12 months.
Medications will be dispensed by a nurse who is blinded to the participants within each
treatment group. Global photograph assessment and participant questionnaires at 0, 4, 8 and
12 months will be the primary means to determine improvement in hair loss.
Compare the following interventions in treating postmenopausal female AGA:
A) Combination 5% Minoxidil and 200mg Spironolactone (Combination Group) B) 5mg Finasteride
with placebo topical preparation (Single Group)
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment